Referensi Tuberkulosis M

1. Ma, J.J., Guo, Y.J., Li, Z., Chen, Y., He, H. and Li, W.M., 2022. Prevalence and prognostic significance of malnutrition risk in patients with pulmonary tuberculosis: a hospital-based cohort study. Frontiers in Public Health, 10, p.1039661.
2. Madaki, S., Mohammed, Y., Rogo, L.D., Yusuf, M. and Bala, Y.G., 2024. Age and gender in drug resistance tuberculosis: a cross-sectional case study at a national tuberculosis reference hospital in Nigeria. Journal of Global Antimicrobial Resistance, 39, pp.175-183.
3. Mafirakureva, N., Cartledge, A., Bradshaw, I., Bekker, A., Salazar-Austin, N., Meehan, S.A., Myer, L., Odayar, J., Rangaka, M.X. and Dodd, P.J., 2026. Global estimates of tuberculosis incidence during pregnancy and postpartum: a rapid review and modelling analysis. The Lancet Global Health.
4. Magee, M.J., Salindri, A.D., Gujral, U.P., Auld, S.C., Bao, J., Haw, J.S., Lin, H.H. and Kornfeld, H., 2018. Convergence of non-communicable diseases and tuberculosis: a two-way street?. The International Journal of Tuberculosis and Lung Disease, 22(11), pp.1258-1268.
5. Magee, M.J., Trost, S.L., Salindri, A.D., Amere, G., Day, C.L. and Gandhi, N.R., 2020. Adults with Mycobacterium tuberculosis infection and pre-diabetes have increased levels of QuantiFERON interferon-gamma responses. Tuberculosis, 122, p.101935.
6. Magodoro, I., Kotze, L., Stek, C.J., West, A., Le Roux, A., Sobratee, N., Taliep, A., Hamada, Y., Dave, J.A., Rangaka, M.X. and Parihar, S.P., 2025. Clinical, metabolic and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies. Expert Opinion on Pharmacotherapy.
7. Magodoro, I.M., Aluoch, A., Claggett, B., Nyirenda, M.J., Siedner, M.J., Wilkinson, K.A., Wilkinson, R.J. and Ntusi, N.A., 2024, October. Association Between Mycobacterium tuberculosis Sensitization and Insulin Resistance Among US Adults Screened for Type 2 Diabetes Mellitus. In Open Forum Infectious Diseases (Vol. 11, No. 10, p. ofae568). US: Oxford University Press.
8. Majaliwa, E.S., Muze, K., Godfrey, E., Byashalira, K., Mmbaga, B.T., Ramaiya, K. and Mfinanga, S.G., 2023. Latent tuberculosis in children and youth with type 1 diabetes mellitus in Dar es Salaam, Tanzania: a cross section survey. BMC Infectious Diseases, 23(1), p.740.
9. Makrufardi, F., Chuang, H.C., Suk, C.W., Lin, Y.C., Rusmawatiningtyas, D., Murni, I.K., Arguni, E., Chung, K.F. and Bai, K.J., 2024. Particulate matter deposition and its impact on tuberculosis severity: A cross-sectional study in Taipei. Science of the Total Environment, 924, p.171534.
10. Mandal, S., Bhatia, V., Bhargava, A., Rijal, S. and Arinaminpathy, N., 2024. The potential impact on tuberculosis of interventions to reduce undernutrition in the WHO South-East Asian Region: a modelling analysis. The Lancet Regional Health-Southeast Asia, p.100423.
11. Mangamba, L.M.E., Halle, M.P., Onana, C.L.M., Tochie, J.N., Ngamby, V., Noubibou, J.C.E., Balkissou, A.D., Tewaffeu, D.G., & Ngahane, B.H.M. (2023). Impact of Chronic Kidney Disease on the Mortality of Tuberculosis Patients: A Cross-Sectional Study in Douala. Health Sciences and Disease, 24(2).
12. Manjourides, J., Lin, H.H., Shin, S., Jeffery, C., Contreras, C., Santa Cruz, J., Jave, O., Yagui, M., Asencios, L., Pagano, M. and Cohen, T., 2012. Identifying multidrug resistant tuberculosis transmission hotspots using routinely collected data. Tuberculosis, 92(3), pp.273-279.
13. Mao, J.J., Zang, X., Yue, W.L., Zhai, P.Y., Zhang, Q., Li, C.H., Zhuang, X., Liu, M. and Qin, G., 2023. Population-level health and economic impacts of introducing Vaccae vaccination in China: a modelling study. BMJ global health, 8(5), p.e012306.
14. Marme, G., Kuzma, J., Zimmerman, P.A., Harris, N. and Rutherford, S., 2024. Investigating socio-ecological factors influencing implementation of tuberculosis infection prevention and control in rural Papua New Guinea. Journal of Public Health, 46(2), pp.267-276.
15. Martinez, L., Zhu, L., Castellanos, M.E., Liu, Q., Chen, C., Hallowell, B.D. and Whalen, C.C., 2017. Glycemic control and the prevalence of tuberculosis infection: a population-based observational study. Clinical Infectious Diseases, 65(12), pp.2060-2068.
16. Matteelli, A., Churchyard, G., Cirillo, D., den Boon, S., Falzon, D., Hamada, Y., Houben, R.M., Kanchar, A., Kritski, A., Kumar, B. and Miller, C., 2024. Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence. PLOS Global Public Health, 4(7), p.e0003306.
17. McQuaid, C.F., Clark, R.A., White, R.G., Bakker, R., Alexander, P., Henry, R., Velayutham, B., Muniyandi, M., Sinha, P., Bhargava, M. and Bhargava, A., 2025. Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study. The Lancet Global Health.
18. Meghji, J., Kon, O.M. and Ainley, A., 2023. Clinical tuberculosis. Medicine, 51(11), pp.768-773.
19. Mendelsohn, S.C., Fiore-Gartland, A., Awany, D., Mulenga, H., Mbandi, S.K., Tameris, M., Walzl, G., Naidoo, K., Churchyard, G., Scriba, T.J. and Hatherill, M., 2022. Clinical predictors of pulmonary tuberculosis among South African adults with HIV. EClinicalMedicine, 45.
20. Meng F, Lan L, Wu G, Ren X, Yuan X,Yang M, Chen Q, Peng X and Liu D (2023). Impact of diabetes itself and glycemic control status on tuberculosis. Front. Endocrinol. 14:1250001.
21. Menzies, N.A., Cohen, T., Lin, H.H., Murray, M. and Salomon, J.A., 2012. Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS medicine, 9(11), p.e1001347.
22. Menzies, N.A., Gomez, G.B., Bozzani, F., Chatterjee, S., Foster, N., Baena, I.G., Laurence, Y.V., Qiang, S., Siroka, A., Sweeney, S. and Verguet, S., 2016. Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models. The Lancet global health, 4(11), pp.e816-e826.
23. Menzies, N.A., Brown, T.S., Imai-Eaton, J.W., Dodd, P.J., Cohen, T. and Martinez, L., 2025. Potential paediatric tuberculosis incidence and deaths resulting from interruption in programmes supported by international health aid, 2025–34: a mathematical modelling study. The Lancet Child & Adolescent Health, 9(11), pp.787-795.
24. Migliori GB, Ong CWM, Petrone L, et al. The definition of tuberculosis infection based on the spectrum of tuberculosis disease. Breathe 2021; 17: 210079.
25. Min, J., Jeong, Y., Kim, H.W. and Kim, J.S., 2024. Tuberculosis notification and incidence: Republic of Korea, 2022. Tuberculosis and Respiratory Diseases, 87(3), p.411.
26. Miyoshi, S., Semba, M., Tanabe, M., Sato, C., Watanabe, A., Ito, R., Kubota, M. and Abe, M., 2025. Assessment of Risk Factors for Death in Older Adult Patients With TB in Japan. CHEST Pulmonary, 3(2).
27. Motta, I., Boeree, M., Chesov, D., Dheda, K., Günther, G., Horsburgh Jr, C.R., Kherabi, Y., Lange, C., Lienhardt, C., McIlleron, H.M. and Paton, N.I., 2024. Recent advances in the treatment of tuberculosis. Clinical Microbiology and Infection, 30(9), pp.1107-1114.
28. Mulaku, M.N., Ochodo, E., Young, T. and Steingart, K.R., 2024. Pre-treatment loss to follow-up in adults with pulmonary TB in Kenya. Public Health Action, 14(1), pp.34-39.
29. Munir, M.A., Khan, S., Rehman, S., Ahmed, D. and Jabbar, A., 2024. Tuberculosis among diabetes patients: a review of epidemiology, pathophysiology, clinical manifestations, and management. Chronicles of Biomedical Sciences, 1(3), pp.PID26-PID26.
30. Murray, M., Oxlade, O. and Lin, H.H., 2011. Modeling social, environmental and biological determinants of tuberculosis. The International Journal of Tuberculosis and Lung Disease, 15(6), pp.S64-S70.
31. Murrill, M.T., Salcedo, K., Tschampl, C.A., Ahamed, N., Coates, E.S., Flood, J., Wegener, D.H. and Shete, P.B., 2025. Policy Impediments to Tuberculosis Elimination: Consequences of an Absent Medicare National Coverage Determination for Tuberculosis Prevention. Journal of Immigrant and Minority Health, pp.1-6.